Advances in CAR T-Cell Therapy for Patients With Hematologic Malignancies

Share

Program Content

Activities

  • CAR T Cell Therapy
    Advances in CAR T-Cell Therapy for Patients With Hematologic Malignancies
    Slideset
    Congratulations: You achieved a completion on 04/09/2022

    Released: March 21, 2025

    Expires: September 20, 2025

Supporters

Supported by an educational grant from Janssen Biotech, Inc. administered by Janssen Scientific Affairs, LLC.

Janssen Biotech, Inc. administered by Janssen Scientific Affairs, LLC